ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: There is also translational evidence for this in vivo: clonal heterogeneity of lower BCR-ABL expression level at diagnosis [16•] is followed by BCR-ABL overexpression as an undisputed hallmark of CML progression [8].